His primary areas of investigation include Magnetic resonance imaging, Radiology, Prostate cancer, Nuclear medicine and Biopsy. His research integrates issues of Oncology, Internal medicine, Retrospective cohort study, Bone marrow and Medical physics in his study of Magnetic resonance imaging. His Radiology research incorporates elements of Multiparametric Magnetic Resonance Imaging and Prostatectomy.
His Prostate cancer study combines topics from a wide range of disciplines, such as Deep learning, Prostate, Lymph node and Medical imaging. His work on Positron emission tomography as part of general Nuclear medicine study is frequently linked to Ligand, bridging the gap between disciplines. The various areas that Heinz-Peter Schlemmer examines in his Biopsy study include Cancer, Diffusion-Weighted MR Imaging, Mammography, Prostate biopsy and Cohort.
Radiology, Magnetic resonance imaging, Nuclear medicine, Prostate cancer and Prostate are his primary areas of study. His Radiology research integrates issues from Prostatectomy and Prostate biopsy. His research in Magnetic resonance imaging intersects with topics in Multiparametric Magnetic Resonance Imaging, Internal medicine, Receiver operating characteristic, Medical physics and Nuclear magnetic resonance.
His work on Positron emission tomography is typically connected to Neuroradiology as part of general Nuclear medicine study, connecting several disciplines of science. Heinz-Peter Schlemmer is studying PET-CT, which is a component of Positron emission tomography. The concepts of his Prostate cancer study are interwoven with issues in Oncology and Urology.
His main research concerns Magnetic resonance imaging, Nuclear medicine, Radiology, Prostate cancer and Prostate. Heinz-Peter Schlemmer has included themes like Internal medicine, Interquartile range, Receiver operating characteristic and Nuclear magnetic resonance in his Magnetic resonance imaging study. The various areas that Heinz-Peter Schlemmer examines in his Nuclear medicine study include Fluid-attenuated inversion recovery, Effective diffusion coefficient, Prospective cohort study and Scanner.
His study in the field of Ultrasound also crosses realms of Neuroradiology. In his study, which falls under the umbrella issue of Prostate cancer, PI-RADS and Oncology is strongly linked to Biopsy. His Prostate study incorporates themes from Positron emission tomography, Ablation and Lesion.
Heinz-Peter Schlemmer mainly focuses on Magnetic resonance imaging, Radiology, Prostate cancer, Prostate and Nuclear medicine. His Magnetic resonance imaging research includes elements of Oncology, Internal medicine, Retrospective cohort study, Receiver operating characteristic and Neuroimaging. His study on Ultrasound and Diffusion Kurtosis Imaging is often connected to Neuroradiology and Kurtosis as part of broader study in Radiology.
As a part of the same scientific family, Heinz-Peter Schlemmer mostly works in the field of Prostate cancer, focusing on Biopsy and, on occasion, PI-RADS, Interquartile range and Diffusion MRI. His studies deal with areas such as Positron emission tomography and Ablation as well as Prostate. He has researched Nuclear medicine in several fields, including Lesion, Progressive disease, Fluid-attenuated inversion recovery, Multiparametric MRI and Brain mri.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Gadolinium Retention in the Dentate Nucleus and Globus Pallidus Is Dependent on the Class of Contrast Agent
Alexander Radbruch;Lukas D. Weberling;Pascal J. Kieslich;Oliver Eidel.
Radiology (2015)
Simultaneous MR/PET Imaging of the Human Brain : Feasibility Study
Heinz Peter W. Schlemmer;Bernd J. Pichler;Matthias Schmand;Ziad Burbar.
Radiology (2008)
PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications
Bernd J. Pichler;Armin Kolb;Thomas Nägele;Heinz Peter Schlemmer.
The Journal of Nuclear Medicine (2010)
Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience.
A. Afshar-Oromieh;A. Afshar-Oromieh;U. Haberkorn;U. Haberkorn;H. P. Schlemmer;M. Fenchel.
European Journal of Nuclear Medicine and Molecular Imaging (2014)
Radiomic profiling of glioblastoma: Identifying an imaging predictor of patient survival with improved performance over established clinical and radiologic risk models
Philipp Kickingereder;Sina Burth;Antje Wick;Michael Götz.
Radiology (2016)
Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".
Annette Pflugfelder;Corinna Kochs;Andreas Blum;Marcus Capellaro.
Journal Der Deutschen Dermatologischen Gesellschaft (2013)
Magnetic resonance imaging of the body trunk using a single-slab, 3-dimensional, T2-weighted turbo-spin-echo sequence with high sampling efficiency (SPACE) for high spatial resolution imaging: initial clinical experiences.
Matthias Philipp Lichy;Beate M. Wietek;John P. Mugler;Wilhelm Horger.
Investigative Radiology (2005)
Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance
Jan P. Radtke;Timur H. Kuru;Timur H. Kuru;Silvan Boxler;Celine D. Alt.
The Journal of Urology (2015)
METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer
Anwar R. Padhani;Frederic E. Lecouvet;Nina Tunariu;Dow Mu Koh.
European Urology (2017)
Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?
Heinz Peter Schlemmer;Heinz Peter Schlemmer;Jonas Merkle;Rainer Grobholz;Tim Jaeger.
European Radiology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University Hospital Heidelberg
German Cancer Research Center
University of Tübingen
German Cancer Research Center
University Hospital Heidelberg
University of Tübingen
Heidelberg University
University of Tübingen
University Hospital Heidelberg
Heidelberg University
University of Oulu
Stanford University
University of Minnesota
Sandia National Laboratories
University of Ottawa
Henan Normal University
Technical University of Munich
MSD (United States)
University of North Carolina at Charlotte
Arizona State University
University of Victoria
University of Malaga
Michigan State University
University of Milan
University of Bristol
Queens College, CUNY